Mitotic control of cancer stem cells

Cancer Discovery

Volumn 3, Issue 2, 2013, Pages 141-144

  Venere, Monica ^a   Miller, Tyler E ^a,b   Rich, Jeremy N ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUB1 RELATED PROTEIN; CENTROMERE PROTEIN E;

ARTICLE; CANCER STEM CELL; CELL CYCLE REGULATION; CELL DEATH; CELL FATE; CELL PROLIFERATION; CELL VIABILITY; CENTROMERE; CYTOTOXICITY; GENE REGULATORY NETWORK; GLIOBLASTOMA; HUMAN; MICROTUBULE ASSEMBLY; MITOSIS; MITOSIS INHIBITION; RNA INTERFERENCE;

ANIMALS; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS; PROTEIN-SERINE-THREONINE KINASES;

EID: 84873923313     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-12-0588     Document Type: Article

References (10)

1. Li L, Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010;327:542-5.
2. Piccirillo SG, Combi R, Cajola L, Patrizi A, Redaelli S, Bentivegna A, et al. Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution. Oncogene 2009;28:1807-1811.
3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolo-mide for glioblastoma. N Engl J Med 2005;352:987-996.
4. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-760.
5. Bie L, Zhao G, Cheng P, Rondeau G, Porwollik S, Ju Y, et al. The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expression. PLoS ONE 2011;6: e25631.
6. Ding Y, Hubert CG, Herman J, Corrin P, Toledo CM, Skutt-K akaria K, et al. Cancer-specifi c requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells. Cancer Discov 2013;3:198-211.
7. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifi es clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010;17:98-110.
8. Gascoigne KE, Taylor SS. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 2008;14:111-122.
9. Kaestner P, Bastians H. Mitotic drugtargets. J Cell Biochem 2010;111: 258-265.
10. Diaz RJ, Golbourn B, Shekarforoush M, Smith CA, Rutka JT. Aurora kinase B/C inhibition impairs malignant glioma growth in vivo. J Neurooncol 2012;108:349-360.